RespireRx Pharmaceuticals Inc. (RSPI)

RespireRx Pharmaceuticals Statistics

Total Valuation

RespireRx Pharmaceuticals has a market cap or net worth of 1.80 million. The enterprise value is 5.39 million.

Market Cap	1.80M
Enterprise Value	5.39M

Important Dates

The next estimated earnings date is Friday, March 28, 2025.

Earnings Date	Mar 28, 2025
Ex-Dividend Date	n/a

Share Statistics

RespireRx Pharmaceuticals has 949.46 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	949.46M
Shares Change (YoY)	n/a
Shares Change (QoQ)	+59.16%
Owned by Insiders (%)	2.55%
Owned by Institutions (%)	n/a
Float	925.23M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-2.48
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.01

Current Ratio	0.01
Quick Ratio	0.00
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-3.23

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-1,104.95%
Return on Capital (ROIC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	-1.09M
Employee Count	2
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +72.73% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+72.73%
50-Day Moving Average	0.00
200-Day Moving Average	0.00
Relative Strength Index (RSI)	55.55
Average Volume (20 Days)	850,897

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	0.16

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-1.41M
Pretax Income	-1.80M
Net Income	-2.17M
EBITDA	n/a
EBIT	-1.41M
Earnings Per Share (EPS)	-0.01

Balance Sheet

The company has 6,362 in cash and 2.78 million in debt, giving a net cash position of -2.77 million or -0.00 per share.

Cash & Cash Equivalents	6,362
Total Debt	2.78M
Net Cash	-2.77M
Net Cash Per Share	-0.00
Equity (Book Value)	-12.30M
Book Value Per Share	-0.04
Working Capital	-11.95M

Cash Flow

Operating Cash Flow	-247,570
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

RespireRx Pharmaceuticals does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-63.45%
Shareholder Yield	-63.45%
Earnings Yield	-656.95%
FCF Yield	n/a

Stock Splits

The last stock split was on January 6, 2021. It was a reverse split with a ratio of 0.1.

Last Split Date	Jan 6, 2021
Split Type	Reverse
Split Ratio	0.1

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a